172 related articles for article (PubMed ID: 32311194)
1. The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort.
Saxby K; Nickson C; Mann GB; Velentzis L; Bromley HL; Procopio P; Canfell K; Petrie D
Aust N Z J Public Health; 2020 Jun; 44(3):219-226. PubMed ID: 32311194
[TBL] [Abstract][Full Text] [Related]
2. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
Moger TA; Bjørnelv GM; Aas E
Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
[TBL] [Abstract][Full Text] [Related]
3. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
4. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
5. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
6. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
7. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
8. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
10. Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
Iwamoto T; Kumamaru H; Miyata H; Tomotaki A; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Matsuoka J; Doihara H; Kinoshita T; Nakamura S; Tokuda Y
Breast Cancer Res Treat; 2016 Apr; 156(3):485-494. PubMed ID: 27048417
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
[TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
13. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
14. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
Trentham-Dietz A; Ergun MA; Alagoz O; Stout NK; Gangnon RE; Hampton JM; Dittus K; James TA; Vacek PM; Herschorn SD; Burnside ES; Tosteson ANA; Weaver DL; Sprague BL
Breast Cancer Res Treat; 2018 Feb; 168(1):229-239. PubMed ID: 29185118
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinomas in situ and invasive cancers detected on screening mammography: Cost-effectiveness of initial and subsequent rounds of population-based program 2007-2014.
Szynglarewicz B; Matkowski R
Adv Clin Exp Med; 2017; 26(2):259-262. PubMed ID: 28791843
[TBL] [Abstract][Full Text] [Related]
17. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
18. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.
Bennett IC; Muller J; Cockburn L; Joshua H; Thorley G; Baker C; Wood N; Brazier J; Jones M; Dunn N; Gattas M
World J Surg; 2010 May; 34(5):979-86. PubMed ID: 20108093
[TBL] [Abstract][Full Text] [Related]
20. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
